Garfield Alastair
5 of 7 shown
The 5 most recent of 7 visible filings, newest first.
- RHYTHM PHARMACEUTICALS, INC. Chief scientific officer$95,335Open-market sale
- RHYTHM PHARMACEUTICALS, INC. Chief scientific officer$402,167Open-market sale
- RHYTHM PHARMACEUTICALS, INC. Chief scientific officer$182,170Open-market sale
- RHYTHM PHARMACEUTICALS, INC. Chief scientific officer$233,031Open-market sale
- RHYTHM PHARMACEUTICALS, INC. Chief scientific officer4,445 sharesOption exercise